Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Stereotactic body radiation therapy (SBRT) stopped the growth of cancer at its original site in the lung for three years among nearly 98 percent of patients with early non-small cell lung cancer (NSCLC) who are unable to have the cancer surgically removed, according to an updated three-year study presented November 2, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Also, see this news bulletin: Gamma Knife Treatment for Glioblastomas Shows Hopeful Results (http://www.medicexchange.com/Groups/Radiology/groups/viewbulletin.html?bulletinid=1002)

What are your thoughts on these stereotactic advances in radiation therapy?